Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Robots.txt file from http://www.03f8a50.netsolhost.com Sitemap: http://www.03f8a50.netsolhost.com/sitemap.xml User-agent: * |
Title | Corino Therapeutics Home |
Description | Search Results Area of Focus Our Pipeline Delivering on the Needs of Patients Corino Therapeutics, Inc. is a private, development-stage biopharmaceutical |
Keywords | Transthyretin, orphan drug, pharmaceutical company, amyloidosis, TTR, polyneuropathy, cardiomyopathy, leptomeningeal, ATTR |
WebSite | corinorx.com |
Host IP | 206.188.192.74 |
Location | United States |
Site | Rank |
US$1,575,805
Last updated: 2023-05-18 12:34:18
corinorx.com has Semrush global rank of 6,716,763. corinorx.com has an estimated worth of US$ 1,575,805, based on its estimated Ads revenue. corinorx.com receives approximately 181,824 unique visitors each day. Its web server is located in United States, with IP address 206.188.192.74. According to SiteAdvisor, corinorx.com is safe to visit. |
Purchase/Sale Value | US$1,575,805 |
Daily Ads Revenue | US$1,455 |
Monthly Ads Revenue | US$43,638 |
Yearly Ads Revenue | US$523,652 |
Daily Unique Visitors | 12,122 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
corinorx.com. | A | 7200 | IP: 206.188.192.74 |
corinorx.com. | NS | 7200 | NS Record: ns58.worldnic.com. |
corinorx.com. | NS | 7200 | NS Record: ns57.worldnic.com. |
corinorx.com. | MX | 7200 | MX Record: 10 mx1.netsolmail.net. |
corinorx.com. | TXT | 3600 | TXT Record: MS=ms23998094 |
Search Results Area of Focus Our Pipeline Delivering on the Needs of Patients Corino Therapeutics, Inc. is a private, development-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products for the treatment of a variety of human diseases, particularly orphan indications. Corino develops technologies that address important unmet medical needs, and which offer improved, cost-effective alternatives to current methods of treatment. Developing a Novel Treatment for ATTR ATTR-Cardiomyopathy hATTR-Polyneuropathy hATTR-Leptomeningeal W e are developing a disease modifying drug called CRX-1008 . CRX-1008 is a potent small molecule TTR stablizer. CRX-1008 is given orally to patients and may treat both peripheral and central ATTR. We have completed multiple clinical proof of concept studies to evaluate the safety, tolerability, and TTR stabilization activity of CRX-1008 . Data from these studies are expected this year as we plan for Phase 2/3 |
HTTP/1.1 200 OK Server: openresty/1.19.9.1 Date: Sat, 18 Jun 2022 08:28:33 GMT Content-Type: text/html Content-Length: 52590 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Wed, 26 Feb 2020 20:12:45 GMT ETag: "cd6e-59f803a45f78f" X-Webcom-Cache-Status: BYPASS Accept-Ranges: bytes |
Domain Name: CORINORX.COM Registry Domain ID: 2075219471_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-09-19T08:41:30Z Creation Date: 2016-11-18T20:36:16Z Registry Expiry Date: 2022-11-18T20:36:16Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS57.WORLDNIC.COM Name Server: NS58.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2022-06-18T08:24:51Z <<< |